[HTML][HTML] Receptor tyrosine kinases: Characterisation, mechanism of action and therapeutic interests for bone cancers

AI Ségaliny, M Tellez-Gabriel, MF Heymann… - Journal of bone …, 2015 - Elsevier
Bone cancers are characterised by the development of tumour cells in bone sites,
associated with a dysregulation of their environment. In the last two decades, numerous …

[HTML][HTML] From Therapy Resistance to targeted therapies in prostate Cancer

F Moreira-Silva, R Henrique, C Jerónimo - Frontiers in Oncology, 2022 - frontiersin.org
Prostate cancer (PCa) is the second most common malignancy among men worldwide.
Although early-stage disease is curable, advanced stage PCa is mostly incurable and …

Multiple Oncogenic Changes (K-RASV12, p53 Knockdown, Mutant EGFRs, p16 Bypass, Telomerase) Are Not Sufficient to Confer a Full Malignant Phenotype on …

M Sato, MB Vaughan, L Girard, M Peyton, W Lee… - Cancer research, 2006 - AACR
We evaluated the contribution of three genetic alterations (p53 knockdown, K-RASV12, and
mutant EGFR) to lung tumorigenesis using human bronchial epithelial cells (HBEC) …

A phase II trial to evaluate gefitinib as second-or third-line treatment in patients with recurring locoregionally advanced or metastatic cervical cancer

A Goncalves, M Fabbro, C Lhommé, L Gladieff… - Gynecologic …, 2008 - Elsevier
BACKGROUND.: Cancer of the cervix occurs in∼ 500000 women worldwide each year, with
prognosis highly dependent on disease stage at diagnosis. Survival times are poor and …

A SOCS-1 peptide mimetic inhibits both constitutive and IL-6 induced activation of STAT3 in prostate cancer cells

LO Flowers, PS Subramaniam, HM Johnson - Oncogene, 2005 - nature.com
Prostate cancer is the second highest cause of cancer-related deaths of men in the US.
Signal transducers and activators of transcription (STATs) proteins are a small family of …

[HTML][HTML] β4 Integrin signaling induces expansion of prostate tumor progenitors

T Yoshioka, J Otero, Y Chen, YM Kim… - The Journal of …, 2013 - Am Soc Clin Investig
There is increasing evidence that prostate cancers in rodent models and in men contain a
cellular subpopulation that displays stem cell properties. These prostate cancer stem cells …

Anticancer effects of the flavonoid diosmetin on cell cycle progression and proliferation of MDA-MB 468 breast cancer cells due to CYP1 activation

VP Androutsopoulos, S Mahale… - Oncology …, 2009 - spandidos-publications.com
Flavonoids constitute a large class of polyphenolic compounds with cancer preventative
properties. We have examined the ability of the natural flavone diosmetin to inhibit …

Cytotoxic effects induced by a combination of cyclopamine and gefitinib, the selective hedgehog and epidermal growth factor receptor signaling inhibitors, in prostate …

M Mimeault, E Moore, N Moniaux… - … journal of cancer, 2006 - Wiley Online Library
Although the blockade of the hedgehog cascade by using cyclopamine has been reported to
inhibit the growth of some cancer cell types, few studies on the mechanism by which this …

Combined targeting of epidermal growth factor receptor and hedgehog signaling by gefitinib and cyclopamine cooperatively improves the cytotoxic effects of docetaxel …

M Mimeault, SL Johansson, G Vankatraman… - Molecular cancer …, 2007 - AACR
The epidermal growth factor receptor (EGFR) and hedgehog cascades provide a critical role
in prostate cancer progression and contribute to the resistance to clinical therapies and …

Transcription factor AP-1 promotes growth and radioresistance in prostate cancer cells

R Kajanne, P Miettinen… - … journal of oncology, 2009 - spandidos-publications.com
Expression of AP-1 proteins has been associated with a more aggressive clinical outcome in
prostate cancer. However, their role and regulation by upstream kinase pathways in …